The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis
Open accessAbstract
We previously reported the discovery of P7C3, an aminopropyl carbazole having proneurogenic and neuroprotective properties in newborn neural precursor cells of the hippocampal dentate gyrus. We have further found that chemicals having efficacy in this in vivo screening assay also protect dopaminergic neurons of the substantia nigra following exposure to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a mouse model of Parkinson disease. Here, we provide evidence that an active analog of P7C3, known as P7C3A20, protects ventral horn spinal cord motor neurons from cell death in the G93A-SOD1 mutant mouse model of amyotrophic lateral sclerosis (ALS). P7C3A20 is efficacious in this model when administered at disease onset, and protection from cell death correlates with preservation of motor function in assays of walking gait and in the accelerating rotarod test. The prototypical member of this series, P7C3, delays disease progression in G93A-SOD1 mice when administration is initiated substantially earlier than the expected time of symptom onset. Dimebon, an antihistaminergic drug with significantly weaker proneurogenic and neuroprotective efficacy than P7C3, confers no protection in this ALS model. We propose that the chemical scaffold represented by P7C3 and P7C3A20 may provide a basis for the discovery and optimization of pharmacologic agents for the treatment of ALS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“P7C3 was shown to be neuroprotective in mouse models of Parkinson disease137, Alzheimer disease157 and ALS158.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [158]
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
Boillée, S., Velde, C. V., & Cleveland, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.018 · Cited by 1,476
Aggregation and Motor Neuron Toxicity of an ALS-Linked SOD1 Mutant Independent from Wild-Type SOD1
Bruijn, L. I., Houseweart, M. K., Kato, S., Anderson, K. L., Anderson, S., Ohama, E., Reaume, A. G., Scott, R. W., & Cleveland, D. W. (1998) · Science · doi:10.1126/science.281.5384.1851 · Cited by 1,250
Rosen, D. (1993) · Nature · doi:10.1038/364362c0 · Cited by 922
COPPER-ZINC SUPEROXIDE DISMUTASE AND AMYOTROPHIC LATERAL SCLEROSIS
Valentine, J. S., Doucette, P. A., & Potter, S. Z. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161647 · Cited by 790
Selective attention enhances the auditory 40-Hz transient response in humans
Tiitinen, H., Sinkkonen, J., Reinikainen, K., Alho, K., Lavikainen, J., & Näätänen, R. (1993) · Nature · doi:10.1038/364059a0 · Cited by 656
Misfolded CuZnSOD and amyotrophic lateral sclerosis
Valentine, J. S., & Hart, P. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730423100 · Cited by 546
Motor Coordination and Balance in Rodents
Carter, R. J., Morton, J. P., & Dunnett, S. B. (2001) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0812s15 · Cited by 479
Doody, R. S., Si, G., Sano, M. C., Thomas, R. G., Aisen, P. S. S., Бачурин, С. О., Seely, L., & Hung, D. S.-Y. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61074-0 · Cited by 458
Tandan, R., & Bradley, W. G. (1985) · Annals of Neurology · doi:10.1002/ana.410180302 · Cited by 365
Discovery of a Proneurogenic, Neuroprotective Chemical
Pieper, A. A., Xie, S., Capota, E., Estill, S. J., Zhong, J., Long, J. M., Becker, G. L., Huntington, P. J., Goldman, S. E., Shen, C.-H., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.018 · Cited by 351
Self-citationPrudencio, M., Hart, P. J., Borchelt, D., & Andersen, P. M. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp260 · Cited by 264
Familial amyotrophic lateral sclerosis
Hand, C. K., & Rouleau, G. A. (2002) · Muscle & Nerve · doi:10.1002/mus.10001 · Cited by 235
Furukawa, Y., Fu, R., Deng, H., Siddique, T., & O’Halloran, T. V. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602048103 · Cited by 225
Antihistamine Agent Dimebon As a Novel Neuroprotector and a Cognition Enhancer
Бачурин, С. О., BUKATINA, E., Lermontova, N., Tkachenko, S. N., Afanasiev, A. V., Grigoriev, V. V., GRIGORIEVA, I., Ivanov, Y. I., Sablin, S. O., & Zefirov, N. S. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03654.x · Cited by 220
Rouaux, C., Panteleeva, I., René, F., de Aguilar, J. G., Echaniz‐Laguna, A., Dupuis, L., Menger, Y., Boutillier, A., & Loeffler, J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1139-07.2007 · Cited by 214
Wang, Q., Johnson, J. L., Agar, N. Y. R., & Agar, J. N. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060170 · Cited by 205
Cruz, S. D., Parone, P. A., Lopes, V. S., Lillo, C., McAlonis‐Downes, M., Lee, S. K., Vetto, A. P., Petrosyan, S., Maršala, M., Murphy, A. N., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.019 · Cited by 183
Development of Proneurogenic, Neuroprotective Small Molecules
MacMillan, K. S., Naidoo, J., Liang, J., Melito, L. M., Williams, N. S., Morlock, L., Huntington, P. J., Estill, S. J., Longgood, J. C., Becker, G. L., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja108211m · Cited by 170
Self-citationMitochondria as a Target for Neurotoxins and Neuroprotective Agents
Бачурин, С. О., Shevtsova, E. F., Kireeva, E. G., Oxenkrug, G. F., & Sablin, S. O. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07541.x · Cited by 169
Pieper, A. A., Wu, X., Han, T. W., Estill, S. J., Dang, Q. T., Wu, L. C., Reece-Fincanon, S., Dudley, C. A., Richardson, J. A., Brat, D. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506713102 · Cited by 150
Self-citationNeuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease
Jesús‐Cortés, H. D., Xu, P., Drawbridge, J., Estill, S. J., Huntington, P. J., Tran, S., Britt, J. K., Tesla, R., Morlock, L., Naidoo, J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213956109 · Cited by 130
Self-citationRecent advances in the genetics of amyotrophic lateral sclerosis
Valdmanis, P. N., Daoud, H., Dion, P. A., & Rouleau, G. A. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0030-9 · Cited by 121
Steele, J., Lachenmayer, M. L., Ju, S., Stock, A., Liken, J., Kim, S. H., Delgado, L. M., Alfaro, I. E., Bernales, S., Verdile, G., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.106 · Cited by 115
Ludolph, A. C., Bendotti, C., Blaugrund, E., Hengerer, B., Loeffler, J., Martin, J. E., Meininger, V., Meyer, T., Moussaoui, S. M., Robberecht, W., et al. (2007) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960701292837 · Cited by 113
Familial amyotrophic lateral sclerosis
Shaw, C. E., Enayat, Z. E., Powell, J. F., Anderson, V., Radunović, A., Al‐Sarraj, S., & Leigh, P. N. (1997) · Neurology · doi:10.1212/wnl.49.6.1612 · Cited by 96
Kariya, S., Ré, D. B., Jacquier, A., Nelson, K. N., Przedborski, S., & Monani, U. R. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds174 · Cited by 54
Models of Amyotrophic Lateral Sclerosis
Jackson, M. T., Ganel, R., & Rothstein, J. D. (2002) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0913s20 · Cited by 16
Muscling In on PGC-1α for Improved Quality of Life in ALS
Johri, A., & Beal, M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.015 · Cited by 4
Flagged first, then by citations
1 of the 31 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- M Letiner, S Menzies, C Lutz Working with ALS mice. Guidelines for Preclinical Testing & Colony Management (The Jackson Laboratory, Bar Harbor, ME. (2010).
Cited by
Sorted by citations
Cantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648
NAD+ metabolism and its roles in cellular processes during ageing
Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00313-x · Cited by 1,617
NAD + in aging, metabolism, and neurodegeneration
Verdin, E. (2015) · Science · doi:10.1126/science.aac4854 · Cited by 1,319
Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
Rajman, L., Chwalek, K., & Sinclair, D. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.011 · Cited by 865
NAD+ homeostasis in health and disease
Katsyuba, E., Romani, M., Hofer, D., & Auwerx, J. (2020) · Nature Metabolism · doi:10.1038/s42255-019-0161-5 · Cited by 627
Metadata
- Authors
- Tesla, R., Wolf, H. P., Xu, P., Drawbridge, J., Estill, S. J., Huntington, P., McDaniel, L., Knobbe, W., Burket, A., Tran, S., Starwalt, R., Morlock, L., Naidoo, J., Williams, N. S., Ready, J. M., McKnight, S. L., & Pieper, A. A.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Departments of bPsychiatry and
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-10
- Volume
- 109
- Issue
- 42
- Pages
- 17016-17021
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3479516
- OpenAlex
- W2158315174
- Cited by
- 129
- References
- 31
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 8 · 2023: 9 · 2022: 3 · 2021: 8 · 2020: 12 · 2019: 8 · 2018: 15 · 2017: 15 · 2016: 11 · 2015: 11 · 2014: 12 · 2013: 7 · 2012: 2
- FWCI
- 6.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01ca095471-10)
- National Institute of Mental Health (R01MH087986)
- National Cancer Institute (P01-CA095471)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Keywords
- amyotrophic lateral sclerosis, neuroprotection, SOD1 G93A mice, motor neuron survival, spinal motoneurons, disease-modifying therapy, early treatment initiation, dimebon, Parkinson's disease, MPTP, dopaminergic neurons, substantia nigra
- MeSH terms
- Amyotrophic Lateral Sclerosis, Animals, Carbazoles, Indoles, Motor Activity, Motor Neurons, Spinal Cord, Polymerase Chain Reaction, Neuroprotective Agents, Rotarod Performance Test, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
